Soligenix starts Phase 2 trial of SGX945 for Behçet's Disease, aiming to enroll 25 patients and report results by mid-2025.

BlackRock has submitted filings to introduce two new money market funds in ETF form on Thursday. These new offerings, named ...

President-elect Donald Trump has picked Rep. Matt Gaetz (R-Fla.) as the nominee for attorney general under the incoming ...

The project originated from Amazon's acquisition of bluDiagnostics in 2020, a startup known for its saliva-based fertility ...

Tech mogul and co-head of Department of Government Efficiency (DOGE), Elon Musk, defended the newly formed body’s efficiency ...

Analysts expect the Raleigh, North Carolina-based company to report quarterly earnings at 54 cents per share, versus a ...

Meme coins have been on the charge this year, as a marked improvement in overall market sentiment has propelled tokens to ...

FBI raids Polymarket CEO's residence for allowing US users to bet on elections, raising concerns of political targeting.

Bitcoin's (CRYPTO: BTC) bullish turn since early September has reflected well on MicroStrategy Inc. (NASDAQ:MSTR), with the ...

BYD reportedly plans to launch passenger cars in South Korea by 2025, competing with Tesla Model 3 and Hyundai IONIQ 6 in the ...

Lawyer Piero Liebman challenges international norms by traveling with medical cannabis, focusing on need for global regs & ...

The final supermoon of 2024 appears on Thursday, with smartphone photography tips such as using a tripod, RAW mode, and apps ...